Graft-versus-host disease of the kidney after rapid tapering of cyclosporin following reduced intensity hematopoietic stem cell transplantation [2]

Bone Marrow Transplantation

Volumn 35, Issue 9, 2005, Pages 929-930

  Homma, C I ^a   Kami, M ^a   Masuo, S ^b   Sakiyama, M ^a   Kojima, R ^a   Hori, A ^a   Kusumi, E ^c   Katori, H ^c   Takeuchi, K ^d   Kishi, Y ^a   Murashige, N ^a   Kim, S W ^a   Takaue, Y ^a   Mitamura, T ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b JR Tokyo General Hospital   (Japan)

^c TORANOMON HOSPITAL   (Japan)

^d CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOSPORIN; CYTARABINE; FLUDARABINE; IDARUBICIN; PREDNISOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; CASE REPORT; DIARRHEA; DISEASE COURSE; DRUG DOSE REGIMEN; ERYTHEMA; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; KIDNEY TUBULE DISORDER; LETTER; MALE; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SIDE EFFECT;

CYCLOSPORINE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KIDNEY FAILURE, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 20844437247     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704896     Document Type: Letter

References (12)

1. Pulla B, Barri YM, Anaissie E. Acute renal failure following bone marrow transplantation. Ren Fail 1998; 20: 421-435.
2. Tsutsumi C, Miyazaki Y, Fukushima T et al. Membranous nephropathy after allogeneic stem cell transplantation: report of 2 cases. Int J Hematol 2004; 79: 193-197.
3. Kimura S, Horie A, Hiki Y et al. Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphoma. Blood 2003; 101: 4219-4221.
4. Davies DR, Bittmann I, Pardo J. Histopathology of calcineurin inhibitor-induced nephrotoxicity. Transplantation 2000; 69 (Suppl): SS11-SS13.
5. Bearman SI, Appelbaum FR, Buckner CD et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562-1568.
6. Panoskaltsis-Mortari A, Price A, Hermanson JR et al. In vivo imaging of graft-versus-host-disease in mice. Blood 2004; 103: 3590-3598.
7. Childs R, Chernoff A, Contentin N et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000; 343: 750-758.
8. Drachenberg D, Childs RW. Allogeneic stem cell transplantation as immunotherapy for renal cell carcinoma: from immune enhancement to immune replacement. Urol Clin North Am 2003; 30: 611-622.
9. Verani RR, Flechner SM, Van Buren CT, Kahan BD. Acute cellular rejection or Cyclosporine A nephrotoxicity? A review of transplant renal biopsies. Am J Kidney Dis 1984; 4: 185-191.
10. Klockars M, Reitamo S, Collan Y. Immunohistochemical identification of renal lysozyme during allograft rejection in man. Histopathology 1979; 3: 433-443.
11. Mielcarek M, Martin PJ, Leisenring W et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003; 102: 756-762.
12. Couriel DR, Saliba RM, Giralt S et al. Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation. Biol Blood Marrow Transplant 2004; 10: 178-185.